Quita Highsmith joined Genentech in 2010 and was selected in 2020, following a number of leadership roles in sales and ...

The executive said the decision to take the company "90 days at a time" was inspired by a "radical experiment" he helped implement at Genentech in 2016 before becoming CEO of the biotech company ...

She will report to Teresa Graham, CEO of Roche Pharma, and become a member of the group’s pharma leadership team. “Ashley is a Roche and Genentech veteran, with a 20-year career that spans the ...

Roche has filled the open CEO position at Genentech with Alexander Hardy, a veteran of the subsidiary. The position has been open since previous CEO Bill Anderson left to head up Roche’s ...

who was previously CEO of Roche’s Pharmaceuticals division after being CEO of Genentech. “What I found was that the bigger the organization, the more it prevented people from just doing what ...

BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé will retire in December, when he will be succeeded by Genentech CEO Alexander Hardy. The transition comes with BioMarin in the early stages of ...

Roche CEO Thomas Schinecker stated: “By investing in a new CVRM centre of excellence, along with data science and AI ...

BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé will retire in December, when he will be succeeded by Genentech CEO Alexander Hardy. The transition comes with BioMarin in the early stages of ...

The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it over to a new center in Harvard’s Enterprise Research Campus. | Roche and ...